Search research articles
Contact Us
Filters
Showing results (181-190 of 217) with videos related to
Page
of 22
Sort By:
Journal of Translational Medicine
|
October 28, 2025
Implementation of precision medicine in treating non-communicable diseases: a systematic review
Shuang Liang, Elizabeth Kennedy, Nyree Gale, et al.
Oncogene
|
October 16, 2023
Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype
Vijesh G Vaghjiani, Catherine R Cochrane, W Samantha N Jayasekara, et al.
Asia-Pacific Journal of Clinical Oncology
|
May 29, 2018
FISH analysis of selected soft tissue tumors: Diagnostic experience in a tertiary center
Ana Cristina Vargas, Christina Selinger, Laveniya Satgunaseelan, et al.
Histopathology
|
July 8, 2016
Atypical Ewing sarcoma breakpoint region 1 fluorescence in-situ hybridization signal patterns in bone and soft tissue tumours: diagnostic experience with 135 cases
A Cristina Vargas, Christina I Selinger, Laveniya Satgunaseelan, et al.
Cancer Research
|
December 17, 2013
Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling
Kathleen I Pishas, Susan J Neuhaus, Mark T Clayer, et al.
The Journal of Cell Biology
|
December 8, 2004
Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma
David M Thomas, Sandra A Johnson, Natalie A Sims, et al.
Cancer Cell
|
December 18, 2014
The architecture and evolution of cancer neochromosomes
Dale W Garsed, Owen J Marshall, Vincent D A Corbin, et al.
JCO Precision Oncology
|
February 27, 2024
Cancer Risks Associated With <i>TP53</i> Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum
Cristina Fortuno, Bing-Jian Feng, Courtney Carroll, et al.
Cancer Discovery
|
September 25, 2012
FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor
Vito Guagnano, Audrey Kauffmann, Simon Wöhrle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2026
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial
Adnan Nagrial, Matteo S Carlino, Ashray Gunjur, et al.
Page
of 22
Search research articles
Search
Showing results (181-190 of 217) with videos related to
Sort By:
Page
of 22
Journal of Translational Medicine
|
October 28, 2025
Implementation of precision medicine in treating non-communicable diseases: a systematic review
Shuang Liang, Elizabeth Kennedy, Nyree Gale, et al.
Oncogene
|
October 16, 2023
Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype
Vijesh G Vaghjiani, Catherine R Cochrane, W Samantha N Jayasekara, et al.
Asia-Pacific Journal of Clinical Oncology
|
May 29, 2018
FISH analysis of selected soft tissue tumors: Diagnostic experience in a tertiary center
Ana Cristina Vargas, Christina Selinger, Laveniya Satgunaseelan, et al.
Histopathology
|
July 8, 2016
Atypical Ewing sarcoma breakpoint region 1 fluorescence in-situ hybridization signal patterns in bone and soft tissue tumours: diagnostic experience with 135 cases
A Cristina Vargas, Christina I Selinger, Laveniya Satgunaseelan, et al.
Cancer Research
|
December 17, 2013
Nutlin-3a efficacy in sarcoma predicted by transcriptomic and epigenetic profiling
Kathleen I Pishas, Susan J Neuhaus, Mark T Clayer, et al.
The Journal of Cell Biology
|
December 8, 2004
Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma
David M Thomas, Sandra A Johnson, Natalie A Sims, et al.
Cancer Cell
|
December 18, 2014
The architecture and evolution of cancer neochromosomes
Dale W Garsed, Owen J Marshall, Vincent D A Corbin, et al.
JCO Precision Oncology
|
February 27, 2024
Cancer Risks Associated With <i>TP53</i> Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum
Cristina Fortuno, Bing-Jian Feng, Courtney Carroll, et al.
Cancer Discovery
|
September 25, 2012
FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor
Vito Guagnano, Audrey Kauffmann, Simon Wöhrle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 24, 2026
Nivolumab and ipilimumab combination treatment in patients with advanced intrahepatic cholangiocarcinoma and gallbladder cancer: Results from the phase II MoST-CIRCUIT trial
Adnan Nagrial, Matteo S Carlino, Ashray Gunjur, et al.
Page
of 22